Carson City, NV 6/2/2010 8:21:39 PM
News / Business

OTC BB News Headlines: DTRO, VCRT, CRGE, IMUC, SGCA

Stocksource.us brings you all the Stocks in the News: Deltron Inc. (OTCBB: DTRO), Vicor Technologies, Inc. (OTCBB: VCRT), Clenergen Corporation (OTCBB: CRGE), ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), Strategic American Oil Corporation (OTCBB:SGCA),

 

 

 

Receive all the news and alerts first. Sign up for the news letter :http://www.stocksource.us

 

 

 

For stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny_stock

 

 

 

Deltron Inc. (OTCBB: DTRO)

 

 

 

 

 

NEW YORK, NY -- 06/02/10 -- Deltron Inc. (OTCBB: DTRO) announced their corporate update yesterday, giving guidance on both wholly owned subsidiaries Blu Vu Life Support Technologies and Elasco, Inc.

 

 

 

Blu Vu, which develops patented rebreather systems for extreme use environments, is expecting its proprietary bailout valve product to be available in the fourth quarter of this year to commercial and recreational users. Market size is estimated to grow at approximately 9% year over year to a $13 billion figure in 2016.

 

 

 

Elasco provides complete design and manufacturing services, from prototype to final casting and injection molding. Elasco, with capabilities to produce 12,000 pounds of polyurethane per day, sells to a diverse clientele including roller skate and skateboard wheels, exercise equipment, automotive suspension, bowling machine parts, potable water distribution, and industrial wheels. The polyurethane market is expected to exceed 8 billion pounds by the end of 2010, approximately $6 billion in sales.

 

 

 

 

Follow our news and alerts with our newsletter sign up today: http://www.stocksource.us

 

***************************************************************************************

 

 

 

 

Vicor Technologies, Inc. (OTCBB: VCRT)

 

 

 

 

 

BOCA RATON, FL -- 06/02/10 -- Vicor Technologies, Inc. (OTCBB: VCRT) today announced that David H. Fater, its President, Chief Executive Officer, and Chairman, will be presenting at ONTRACK 2010, Noble Financial's Sixth Annual Equity Conference, June 7-8, 2010, at the Hard Rock Hotel in Hollywood, FL. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i® nonlinear algorithm and software. Vicor develops diagnostics that accurately risk stratify specific target populations for future pathological events including cardiac death and autonomic nervous system dysfunction, and trauma victims in need of lifesaving intervention.

 

 

 

Mr. Fater will describe Vicor's technology, product commercialization status, and future strategy at 2:00pm EDT on Monday, June 7, in room 3: Piquet. Mr. Fater and other members of the Company's senior management team will be available for one-on-one meetings during the two days of the conference.

 

 

 

Sign up for our newsletter: http://www.stocksource.us

 

********************************************************************************

 

 

 

Clenergen Corporation (OTCBB: CRGE)

 

 

 

 

 

NEW YORK, NEW YORK -- 06/02/10 -- Clenergen Corporation (OTCBB: CRGE) today announced that the company's wholly-owned subsidiary, Clenergen India Private Limited, completed its acquisition of an 1.5 MWe biomass power plant located near Salem, Tamilnadu, India. The power plant is a turnkey, fully operational facility which generates electricity through an anaerobic digestion process using chicken litter as the biomass feedstock. The purchase price of approximately $1.65 million (based on current exchange rates) was funded through financing provided by the Indian Renewable Energy Agency, other loans and recent private equity sales of Clenergen Corporation common stock. The acquisition price represents a savings of approximately $1 million from the plant's construction costs. It is anticipated that the plant, which is connected to the Indian national power grid, will commence operations and generation of renewable electricity on June 15, 2010.

 

 

 

The company intends to sell the electricity through short term power purchase agreements with direct end users at an average price of US $0.14-18 KW/h, which will generate an estimated US $1.2-$1.8 million per annum in revenues if maximum generation capacity is reached and all such electricity is sold. The contracts will be incorporated under an umbrella power purchase agreement that Clenergen entered into with Power Trading Corporation of India Limited. Clenergen will pay a 10% fee in return for guaranteed monthly payments for all electricity generated. The plant converts the chicken litter feedstock into methane gas through an anaerobic process and the methane gas is then used to power the plants GE Jenbacher turbine engines. A bi-product of the anaerobic process is compost that can be processed into fertilizer. Clenergen anticipates using the fertilizer at energy crop plantations for supplying fuel for future power generating facilities. Clenergen believes that the Salem plant will generate up to 31.75 tons (US) of compost a day which could result in a savings of approximately $3 million of fertilization costs (equal to the fertilizer costs to support 3,750 acres of plantation land).

 

 

 

 

 

Follow our news and alerts with our newsletter sign up today: http://www.stocksource.us

 

 

 

***************************************************************************************

 

 

 

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC)

 

 

 

LOS ANGELES--(June 2, 2010)-- ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that data from a recent clinical trial of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago. The presentation, "Immune response correlation with progression-free survival in glioblastoma following dendritic cell immunotherapy (ICT-107)," features data showing ICT-107 provided a significant increase in survival in patients who received the vaccine.

 

 

 

In the Phase I clinical study of ICT-107 in GBM, newly diagnosed patients who received the vaccine in addition to the standard of care of surgery, radiation and chemotherapy demonstrated a one year overall survival of 100 percent and a two year survival of 80 percent. This compares favorably with historical 61.1 percent one-year and 26.5 percent two-year survival based on the standard of care alone. The median overall survival has not yet been reached at the 26.4 months analysis point, with 12 out of 16 patients alive (75% percent).

 

 

 

Sign up for our newsletter: http://www.stocksource.us

 

**************************************************************************************

 

 

 

Strategic American Oil Corporation (OTCBB:SGCA)

 

 

 

CORPUS CHRISTI, Texas, June 2, 2010 -- Strategic American Oil Corporation (OTCBB:SGCA) (the "Company") is pleased to announce it has completed leasing the DST prospect in the Illinois Basin. The project covers approximately 1,000 acres and according to the Illinois State Geological Survey (ISGS) is on trend with and offsets fields that have produced from 764,600 to 3,570,500 barrels of oil from depths of 3,000 to 4,000 feet. The Company will now work to secure additional working interest partners in an effort to drill an offset well on the DST acreage. This prospect was identified from geologic and historic well information provided by the ISGS.

 

 

 

The DST prospect is a part of broader effort by the Company to create a package of drilling prospects ranging from lower risk offsets to higher risk step-out wells. This portfolio of prospects will provide SGCA and its working interest partners a relatively low risk/high reward portfolio of drilling locations in the heart of the Illinois Basin where, according to the ISGS, recent calculations suggest that remaining mobile resources in the Illinois Basin may be as much as 4.1 billion barrels.

 

 

 

The Illinois Basin

 

Strategic American Oil Corporation has a strong interest in developing oil from primary and secondary recovery in the Illinois Basin for numerous reasons, including:

 

-- Low lease costs at $10-25/acre

 

-- Low royalty rate at 12.5 percent

 

-- Shallow target zones of 2,000 -- 4,000 feet

 

 

 

 

 

According to ISGS, oil and gas have been commercially produced in Illinois for over 100 years. Existing commercial production comes from more than 52 named pay horizons. Recent calculations suggest that remaining mobile resources in the Illinois Basin may be as much as 4.1 billion barrels. Thus, large quantities of oil, potentially recoverable using current technology, remain in Illinois oil fields despite a century of development. To date, Strategic American Oil has leased more than 3,500 acres covering numerous prospects in Illinois.

 

 

 

Strategic American Oil Corporation President and CEO Jeremy Driver stated, "Like our Koliba prospect in Texas, the DST prospect was identified and leased in-house. We are now in a position to develop internal engineering reports that will allow us to secure working interest partners to move the prospect towards the drilling stage while creating a low risk/high reward scenario. Initial evaluation of surrounding well control for this prospect shows tremendous promise and we look forward to developing it to its full potential. As our Chairman Randall Reneau previously stated, by utilizing the ISGS database to review current and historic oil fields with similar geologic characteristics to the Company's current leases, we are able to compare the potential of our primary as well as secondary recovery prospects in the Basin. These shallow oil trends offer the possibility of near-term production and significant cash flow at minimum risk."

 

 

 

********************************************************************************

 

 

 

 

 

For A Comprehensive Coverage of Stock Please Visit:

 

http://www.stocksource.us

 

E-mail: info@StockSource.us | Phone number: 858-750-9041

 

For stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny_stock

 

StockSource.us offers a newsletter covering companies traded on the OTC, OTCBB, PINKSHEETS and AMEX stock exchanges. Subscribers to our newsletter will receive up to date time sensitive press releases and profiles on featured companies traded on various small cap stock exchanges such as otc, otcbb, pinksheet and amex. Other sectors we cover are: alternative energy stocks/companies (solar stocks, wind stocks, hydro stocks, nuclear stocks, uranium stocks, biofuel stocks, clean coal stocks) as well as oil and gas stocks, gold stocks and mining stocks.

 

Iron Consulting Inc. delivers a broad spectrum of services designed to meet your goals and fit your budget. They include: Search Engine Optimization, Email Campaigns, Financial News Distribution and Media Exposure, CEO Interviews, Analyst Reports, Investment Opinion Services, Web Design and Development, Audio & Video Profiles and Shareholder Communications.

 

StockSource.us is owned and operated by Iron Consulting.

 

Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), StockSource.us is owned and operated by Iron Consulting. Iron Consulting has received twenty five thousand from Equity Alliance Intl. for a one month internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

 

(с) 2006 StockSource.us All Rights Reserved. Disclaimer

 

E-mail: info@StockSource.us

 

Phone number: 858-750-9041